19Apr 2025
Osimertinib Induces TRAIL-Mediated Apoptosis in EGFRm NSCLC Cells

Osimertinib Induces TRAIL-Mediated Apoptosis in EGFRm NSCLC Cells

Osimertinib induces apoptosis in EGFR mutant (EGFRm) NSCLC cells through TRAIL (TNFSF10) upregulation, which is mediated by IL6/STAT3 signaling. This study reveals that osimertinib activates STAT3 to increase TRAIL expression and enhances DR5 clustering, crucial for apoptosis. The findings highlight TRAIL’s role in osimertinib efficacy and resistance mechanisms, presenting new insights into targeting the IL6/STAT3/TRAIL axis to improve NSCLC treatment outcomes.

  • #oncology

Like

Save

Share